Mill Creek Capital Advisors’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Mill Creek Capital Advisors’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-8,400	Closed	-$202K	–	264
2023 Q1	$202K	Buy	+8,400	New	+$105K	0.01%	230

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Mill Creek Capital Advisors's PRVB Position: Q2 2023 in Review

Mill Creek Capital Advisors sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 8,400 shares — an estimated $202K sold.

Mill Creek Capital Advisors first reported a position in PRVB in Q1 2023 and held it in 1 quarter. The position peaked at $202K in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Mill Creek Capital Advisors reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Mill Creek Capital Advisors sold 8,400 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $202K.
Mill Creek Capital Advisors first reported a position in Provention Bio, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
Mill Creek Capital Advisors's Provention Bio, Inc. Common Stock position peaked at $202K in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Mill Creek Capital Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.